The Washington Times | Promising therapies for terminal patients advance while approval remains stagnant
https://www.washingtontimes.com/news/2021/jun/29/promising-therapies-for-terminal-patients-advance-/
New and promising therapies for patients with serious life-threatening diseases are advancing, but Congress must modernize review pathways at the FDA and do so in a manner that maintains its role in...